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Introduction: Type 2 diabetes is associated with an increased risk of bone fractures. 
However, bone health of women with a history of gestational diabetes (GDM) has received 
little attention. This cross-sectional study compares bone health between premenopausal 
women with and without a history of GDM, and examines factors associated with bone health 
in women with a history of GDM or obesity. Material and methods: We measured areal 
bone mineral density for total hip, lumbar spine and whole body, and total body fat 
percentage (fat%) with dual-energy X-ray absorptiometry in 224 women. In addition, we 
measured bone characteristics of radius and tibia with peripheral quantitative computed 
tomography. Results: When compared to women without a history of GDM (mean age 39 
[SD 5], BMI 35 [6], fat% 48 [7]), women with a history of GDM (age 41 [4], BMI 31 [7], 
fat% 43 [10]) had lower hip and whole body bone mineral densities, and inferior tibia 
outcomes. However, the differences in bone characteristics attenuated after controlling for 
age, height, BMI and fat%. After controlling for age, height, BMI and smoking, physical 
activity and healthier diet were positively associated with bone outcomes, whereas fat%, 
HbA1c and screen time were negatively associated with bone outcomes. Particularly, fat% 
showed independent negative associations with whole body bone mineral density and several 
tibia and radius characteristics. Conclusions: Fat% is associated with adverse bone health, 
independently of BMI, in women with a history of GDM or obesity. Promoting healthy 
lifestyle and reducing fat% in women with a history of GDM or obesity could improve bone 
health and prevent future fractures.  
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Bone fractures in women with a history of gestational diabetes or obesity could possibly be 







Along with obesity, the prevalence of type 2 diabetes (T2D) is increasing worldwide 1,2. In 
addition to several other complications, T2D is associated with an increased risk of bone 
fractures 3,4. This is of importance because fractures impair quality of life, induce disability, 
increase health care costs and even mortality 5–8. The increased risk of fractures in T2D is 
caused by diabetes-associated alterations in bone quality, defined as diabetoporosis 9. 
Diabetes-associated alterations in bone are proposed to be related to the duration of T2D, 
impaired glycemic control and chronic inflammation 4,10,11. However, it is unclear how early 
the diabetes-induced alterations in bone health occur. 
Alarmingly, also the prevalence of gestational diabetes mellitus (GDM) is increasing 
worldwide 12. GDM, defined as impaired glucose tolerance with onset or first recognition 
during pregnancy, is a major risk factor for future T2D 13,14. Although GDM usually resolves 
after giving birth, women with GDM have up to a 7-fold increased risk for T2D during the 
next five to ten years 14. Women with a history of GDM may present with prediabetes, which 
means that their blood glucose level may be higher than normal but lower than the diagnostic 
threshold for T2D. Several healthy lifestyle factors improve bone health, whereas physical 
inactivity, a nutrient-poor-energy-dense diet and smoking deteriorate bone health 15–19. 
Studies suggest that women at risk for GDM have poorer diet quality and low levels of 
physical activity 20–22, which could affect their bone health. 
There is a lack of studies examining bone health of women with a history of GDM. 
Furthermore, identifying factors related to bone health in women at risk for T2D should be 
addressed. Knowledge on the early changes in, and factors associated with bone quality could 
be helpful in developing preventive strategies for diabetes-associated alterations in bone. To 
the best of our knowledge, this study examines for the first time the bone health of women 
with a history of GDM and/or obesity. We aim to 1) compare bone health between women 
with and without a history of GDM, and 2) identify factors associated with bone health among 
women with a history of GDM or obesity. 
 
2 MATERIAL AND METHODS 
2.1 Study design 
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This cross-sectional study examines follow-up data of the Finnish Gestational Diabetes 
Prevention Study (RADIEL). The RADIEL study is a randomized controlled intervention trial 
conducted in four maternity hospitals in Finland between the years 2008 and 2014. The main 
objective of the RADIEL study was to assess the efficacy of a lifestyle intervention in 
preventing GDM among women at high risk for the disease, i.e. women with a history of 
GDM and/or prepregnancy obesity 23. This cross-sectional analysis utilizes the follow-up data 
of the RADIEL study collected between September 2016 and March 2017, and treats the 
subjects as a cohort of women with a history of GDM or obesity. 
 
2.2 Participants 
Eligible participants for the original RADIEL study were women either planning pregnancy 
or pregnant at <20 weeks of gestation, 18 years old, and with either a history of GDM and/or 
prepregnancy body mass index (BMI) 30 kg/m2. The women were at high risk for GDM, 
since high BMI and GDM in a previous pregnancy are major risk factors for GDM 24,25. The 
detailed inclusion and exclusion criteria for the RADIEL study are described elsewhere 23. We 
invited the women from the Helsinki metropolitan area who gave birth and had at least one 
RADIEL study visit during pregnancy to a follow-up about six years after the RADIEL index 
delivery. The 6-year follow-up included bone health and anthropometric measurements, and 
the women completed a questionnaire on health- and  lifestyle-related factors. In this analysis, 
we include the women who participated in the 6-year follow-up.  
 
2.3 Measurements 
In this study, a history of GDM refers to women having a diagnosis of GDM either before 
participating in the RADIEL study, or in the index pregnancy of the RADIEL study. Thus, 
GDM was diagnosed on average six years (range 3-8 years) before the bone measurements. 
GDM diagnosis prior to the RADIEL study was verified from the hospital registries. GDM in 
the index pregnancy of the RADIEL study was defined as one or more pathological glucose 
value in a 2-hour 75g oral glucose tolerance test (OGTT) either in the first or second trimester 
of pregnancy, with the diagnostic thresholds of fasting plasma glucose ≥5.3 mmol/L, 1-hour 
value ≥10.0 mmol/L, and 2-hour value ≥8.6 mmol/L. At the 6-year follow-up, the 
participants’ glycosylated hemoglobin (HbA1c) was measured to assess blood glucose level 
over time. A study nurse measured the subjects’ height and weight, and BMI was calculated. 
In addition, we measured total body fat percentage (fat%) with dual-energy X-ray 
absorptiometry (DXA). The women reported dates of their deliveries, osteoporosis diseases 
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(conditions that last for a long time and require ongoing medical attention and/or limit 
activities of daily living), medication (regular or irregular; for example for pollen allergies), 
prior fractures and whether they have osteoporosis (a health condition that weakens bones, 
making them fragile and more likely to break) in the immediate family with a questionnaire.  
We assessed lifestyle behaviors with a questionnaire. The women answered questions 
on supervised and unsupervised physical activity during leisure-time, commuting physical 
activity, and screen time during leisure-time. Based on the answers, we report participants’ 
supervised leisure-time physical activity, total leisure-time physical activity, total physical 
activity, and leisure-time screen time in minutes per day. We assessed food intake with a 50-
item food frequency questionnaire (FFQ) with additional questions on special diets, quality of 
dietary fats and eating lunch during the preceding week. We created a Healthy Eating Index 
(HEI) based on seven FFQ items regarding whole grains, quality of dietary fat, red meat, 
dairy products, fish and vegetables/fruits/berries. The maximum score in HEI is 35, with a 
higher score indicating healthier and more balanced Nordic diet 26. In addition, the women 
answered a question on smoking habits (yes, no, previously). 
We measured areal bone mineral density (BMD; g/m2) for total hip, lumbar spine (L1-L4) 
and whole body with DXA (Lunar Prodigy Advance DXA; GE Healthcare; Madison, WI) in 
subjects with weight <160 kg. T-scores, standard deviations from the peak BMD, for each 
skeletal site was derived using a young Finnish female reference population 27. The 
measurements were calibrated daily with a spine phantom. Reproducibility of DXA 
measurement for total body is: BMD = 0.85%, bone mineral content = 0.45% and bone area = 
0.78% 28.  
In addition, we measured bone geometry and volumetric density of radius and tibia with 
peripheral quantitative computed tomography (pQCT) (XCT-2000; Stratec; Pforzheim; 
Germany; software version 6.20). The repeatability of the pQCT was evaluated with 
measurements of phantom provided by the manufacturer. We measured radius at distal (4 %) 
and proximal (66 %) sites, and tibia at distal (4 %) and diaphyseal (33 %) sites. We report the 
following variables for distal sites of radius and tibia: total bone mineral content (BMC; 
g/cm), total cross-sectional area (TotCSA; mm2), total volumetric density (TotDen; mg/cm3) 
and trabecular volumetric density (TrabDen; mg/cm3). For the proximal site of radius and the 
diaphyseal site of tibia, we report BMC, polar strength strain index (SSIPOL; mm3), TotCSA, 





2.4 Statistical analyses 
We examined normal distribution of the variables in the whole cohort and separately for the 
women with and without a history of GDM visually and with the Shapiro-Wilk test. We 
applied logarithmic transformations if needed. We compared the differences in 
anthropometric, health, lifestyle and bone characteristics between the women with and 
without a history of GDM with the Chi-square test, the Mann-Whitney U test or the 
independent sample T-test, when appropriate. Moreover, we identified variables associated 
with bone characteristics with the Spearman’s rank-order correlation, adjusting for variables 
commonly associated with bone health (age, height, BMI and smoking status). We considered 
the variables associated with the bone characteristics as mediators and used those as 
additional covariates in further analyses. We performed the Multivariate analysis of 
covariance (MANCOVA) to evaluate the differences in the bone characteristics between 
women with and without a history of GDM when adjusting for age, height, BMI and fat%. 
We performed the analyses for those with all the needed variables available, and report the 
numbers of subjects included in each analysis. We performed the statistical analyses with the 
SPSS 25.0 software program (SPSS Inc., Chicago, IL, USA) and considered a P value < 0.05 
as statistically significant. 
 
2.5 Ethical approval 
The RADIEL study is conducted in compliance with the World Medical Association 
Declaration of Helsinki — Ethical Principles for Medical Research Involving Human 
Subjects. Ethical approval was obtained from the Research Ethics Committees of the Hospital 
District of Helsinki and Uusimaa and the South-Karelia Central Hospital (HUS/42/2017, 
HUS/1268/2016), and the study protocol is registered at clinicaltrials.gov (NCT01698385). 




We invited 516 women from the original RADIEL study to the 6-year follow-up 
measurements, among which 229 participated. We were unable to perform the bone 
measurements to one woman who weighted 165 kg, and four women were excluded from the 
RADIEL study or withdrew their consent, and thus not included this analysis. Finally, we 
included 224 women. 
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Table 1 presents characteristics of the women with and without a history of GDM. The 
most common chronic diseases among the women were musculosceletal disease/symptoms 
(n=16, 7%) and asthma/allergy (n=11, 5%). Table 2 shows the bone charateristics of the 
women. Women with a history of GDM were older, and their BMI and fat% were lower 
compared to women without a history of GDM. Moreover, women with a history of GDM 
had higher HbA1c values. Other health or lifestyle characteristics did not differ between the 
groups. 
Table 2 shows unadjusted differences in the bone characteristics between women with 
and without a history of GDM. Women with a history of GDM had lower hip BMD, whole 
body BMD, BMC in distal tibia, and lower BMC, SSIPOL, TotCSA and CortCSA in 
diaphyseal tibia. After adjusting for age, height, BMI and fat% these differences attenuated 
between the groups. However, the difference became significant for SSIPOL in proximal 
radius (P = 0.018), with lower adjusted means (274.3, standard error of the mean [SEM] 4.6) 
for women with a history of GDM when compared to women without a history of GDM 
(294.0, SEM 6.5). Based on the T-score cut-off values, none of the participants had 
osteoporosis (T-score of -2.5 or lower). Nine (6%) of the women with a history of GDM and 
four (5%) of the women without a history of GDM had osteopenia (T-score of -1 to -2.5) in at 
least one of the bone sites measured with DXA (hip, lumbar spine or whole body). The 
difference between the groups in osteopenia was not statistically significant. 
Table 3 presents the associations of the bone characteristics with health- and lifestyle-
related factors. In summary, after adjusting for age, height, BMI and smoking status (i.e. 
typical factors affecting bone health), fat% showed the strongest correlations and was 
inversely associated with most of the bone characteristics. Other factors associated with bone 
characteristics were HbA1c, supervised leisure-time physical activity, total leisure-time 
physical activity, total physical activity, screen time and HEI. Years since last delivery were 
not associated with bone characteristics (Table 3).  
We additionally examined the crude correlations between fat% and other factors 
associated with bone health, and detected a positive association between fat% and HbA1c (rs = 
0.272, P < 0.001), and negative associations between fat% and supervised leisure-time 
physical activity (rs = -0.216, P = 0.001), total leisure-time physical activity (rs = -0.278, P < 
0.001), total physical activity (rs = -0.214, P = 0.002) and HEI (rs = -0.217, P = 0.002). 
After adding fat%, HbA1c, supervised leisure-time physical activity, screen time and 
HEI as covariates for each other, fat% continued showing independent inverse associations 
with 13 out of the 23 bone characteristics (Table 4). Supervised leisure-time physical activity 
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showed positive independent associations with two distal tibia characteristics, whereas HEI 
showed positive independent associations with two diaphyseal tibia characteristics. HbA1c and 
screen time were not independently associated with the bone characteristics (Table 4). 
 
4 DISCUSSION   
 
This study examined for the first time the bone health of women with a history of GDM 
and/or obesity. The results showed that woman with a history of GDM did not have adverse 
bone characteristics compared to women without a history of GDM but with excess weight 
after adjustments for age, height, BMI and fat%. Furthermore, fat%, physical activity and diet 
were associated with bone health in women with a history of GDM or obesity. Fat% showed 
the strongest correlations and was negatively associated with several bone characteristics, 
independently of BMI and other health-related factors. 
Our cohort consists of a unique sample of 224 high-risk women who had either a history 
of GDM (with or without obesity) or prepregnancy obesity, which resulted in considerable 
variation in BMI, fat% and lifestyle factors. Nevertheless, most of the women were currently 
obese and the mean fat% was high (44%). Among the women, 146 had a history of GDM but 
the current HbA1c values of the women were within the normal range in both groups. 
Moreover, the women mostly had mild GDM: only about 30% of the women who participated 
in the RADIEL study and had GDM in the index pregnancy needed insulin or metformin 
treatment 29,30. This could be the reason for detecting no difference in bone health between 
women with and without a history of GDM after the adjustments. Another reason may be that 
the diabetes-induced alterations in bones do not yet occur in 40-year-old women but later in 
life. Furthermore, we did not have a control group of women with similar BMI to those with a 
history of GDM. However, based on the BMD T-scores, none of the women had osteoporosis 
and only 5-6% had osteopenia in both groups, showing that also the women with a history of 
GDM had normal bone health when compared to reference values of young Finnish women. 
Nevertheless, the T-scores do not take into account BMI. Obesity protects from osteoporosis 
but the relative BMD for BMI may be lower in obese women compared to normal-weight 
women, which might contribute to a higher risk of fractures 31.  
One previous cohort study of 480 women, among which 96 had GDM, reported greater 
BMD losses from early pregnancy to third trimester of pregnancy in women with GDM when 
compared with women without GDM 32. Within women with GDM, lower initial BMD 
values, higher fat accumulation and higher early-pregnancy BMI were associated with lower 
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BMD loss. However, they did not control for BMI when examining the association between 
fat and bone loss. The authors concluded, in accordance with our findings, that although 
women with GDM had greater BMD loss than non-diabetic women, the difference was 
apparently explained by anthropometric factors rather than directly by the gestational diabetic 
state 32.  
Our initial analyses showed that after controlling for typical factors affecting bone health 
(age, height, BMI and smoking status), fat%, HbA1c, physical activity (especially supervised), 
screen time and food intake were associated with bone outcomes in women at risk for T2D. 
HbA1c was associated with an increased bone fracture risk in a Chinese prospective study of 
20,000 older people with T2D 10, while sedentary lifestyle and obesity are suggested to 
contribute to the development of diabetoporosis 9. Similarly to our results, another study 
showed that supervised leisure-time physical activity was positively associated with bone 
characteristics in normal-weight and obese young adults, and HEI in normal-weight young 
adults 33. In the present study, higher fat% was associated with lower physical activity levels 
and poorer diet, indicating an interaction between these factors. We assessed physical activity 
and diet with self-reported measures, which may be biased due to under- and overreporting. 
Therefore, the objectively measured fat% may be more accurate indicator of lifestyle 
behaviors. 
Higher fat% was negatively associated with whole body BMD and several radius and 
tibia outcomes even after adjusting for BMI, age, height, HbA1c, supervised physical activity, 
screen time and HEI. A previous study of 122 postmenopausal women with T2D compared 
DXA-derived BMD between women with prevalent vertebral fracture and those without 
osteoporosis or low-trauma fractures, and found lower BMD only at the distal radius in the 
vertebral fracture group 34. The results suggest that distal radius may be the best site to assess 
fracture risk in T2D patients 34, and are in accordance with another study reporting increased 
cortical porosity at the distal radius and tibia, as measured with pQCT in postmenopausal 
diabetic women who have fragility fractures 35. Higher cortical porosity is reported in women 
with fractures (with and without diabetes) 36–38, while studies in women with diabetes are 
controversial by showing both lower and higher cortical porosity 39. Our results suggest that 
women with a history of GDM or obesity who have high fat% may be at risk for fractures in 
the future. 
The previous research evidence regarding the relation between body fat and bone health 
in healthy populations is somewhat conflicting. Epidemiological studies indicate that high fat 
mass is positively correlated with high bone mass in both premenopausal and postmenopausal 
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women 40,41. Nevertheless, these studies did not adjust for the mechanical loading effects of 
body weight on bone mass. Similarly to our results, other studies have shown that after 
adjusting for body weight/BMI, the excess adipose tissue has a negative or no correlation with 
bone outcomes 42,43. A study of 502 healthy subjects detected an inverse correlation between 
fat% and lumbar spine BMD after adjusting for age and body weight in premenopausal 
women, but not in men or in postmenopausal women 44. Furthermore, only among the 
premenopausal women, the women with the highest quartile of fat % had the lowest BMD 
even after adjusting for age, body weight, physical activity, alcohol use and smoking history 
44. Another previous cross-sectional study found that a relative bone strength index, a ratio of 
bone strength to load from body weight, was inversely associated with fat mass in 11-year-old 
girls, their premenopausal mothers and postmenopausal grandmothers, but remained 
relatively constant with increasing lean mass in the girls and premenopausal women 45. The 
results indicate that the bone-strength deficit is attributable to increased fat mass, not to lean 
mass 45. The results from these previous studies are in accordance with our results, and 
suggest that the beneficial effects of higher weight on bone, if any, do not compensate for the 
adverse effects of body fat. Possible mechanisms behind the adverse effects of body fat on 
bone health include obesity-related low-grade inflammation, which is associated with 
impaired bone characteristics 46. 
The strengths of our study include a cohort of over 200 women with a history of GDM 
and/or obesity. The women recruited for the RADIEL study represent the heterogenic 
population of women at high risk for GDM, because in addition to obese women also women 
with normal BMI who had a history of GDM were included. However, the women were 
initially recruited for a lifestyle intervention study and highly educated (32% with an 
academic degree), and therefore may not be representative of the whole high-risk population 
47. BMI did not differ between the women who initially participated in the RADIEL study and 
women who participated in the 6-year follow-up (mean 32 kg/m2 in both) 47. We measured 
fat% with DXA, which is considered the most accurate measure of body composition and 
reliable also in obese adults 48. We assessed bone health with two different densitometry 
techniques, which provide valuable evidence both for clinicians working with DXA and for 
researchers utilizing pQCT. We did not, however, measure bone turnover markers, which 
would have provided insight on the possible metabolic changes in bone. Limitations of the 
study include the cross-sectional study design, and therefore we cannot draw any conclusions 






Woman with a history of mild GDM did not have adverse bone health compared to women 
without a history of GDM but with excess weight after adjusting for confounding factors. 
Among women with a history of GDM or obesity, higher fat% was associated with adverse 
bone health, independently of BMI. Previous research evidence shows that diabetes-induced 
alterations and related fractures are clinically significant and commonly underestimated 
problems in patients with T2D 3,9. Bone fractures in high-risk women could possibly be 
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Table 1 Characteristics of women with and without a history of gestational diabetes (n = 224*) 
 
Characteristic All A history of gestational diabetes P 
  Yes 
n = 146 
No 
n = 78 
 
Age (years) 40.3 (4.6) 41.0 (4.4) 39.1 (4.7) 0.004a 
Height (cm) 166.5 (6.4) 165.9 (6.2) 167.5 (6.6) 0.082a 
Current BMI (kg/m2) 32.2 (7.0) 30.7 (7.3) 34.9 (5.7) < 0.001b 
Current obesity (BMI ≥ 30 kg/m2), % 58.5 47.9 78.2 < 0.001c 
Fat% 44.4 (9.3) 42.5 (9.7) 48.1 (7.4) < 0.001b 
HbA1c (mmol/mol) 34.1 (3.5) 34.7 (3.6) 33.0 (2.8) 0.001b 
Years since latest delivery 5.4 (1.8) 5.6 (1.7) 5.1 (1.8) 0.052b 
Chronic disease, % 20.5 20.6 22.1 0.068c 
Regular or irregular medication, % 58.5 58.6 58.4 1.000c 
Prior fracture, % 42.5 41.5 44.2 0.819c 
Osteoporosis in immediate family, % 17.8 29.7 14.3 0.418c 
Current smoker, % 11.2 8.3 16.7 0.095c 
Current or previous smoker, % 17.0 13.8 23.1 0.116c 
Supervised leisure-time physical 
activity (min/day) 
5.3 (9.4) 5.1 (8.6) 5.7 (10.7) 0.629b 
Total leisure-time physical activity 
(min/day) 
26.2 (29.6) 27.6 (33.8) 23.7 (19.6) 0.638b 
Total physical activity (min/day) 35.9 (32.8) 37.4 (36.6) 33.0 (24.2) 0.574b 
Leisure-time screen time (min/day) 128.8 (76.7) 127.0 (77.3) 132.2 (75.9) 0.577b 
Healthy Eating Index (HEI) (score 0--
35)  
20.1 (5.5) 20.6 (5.4) 19.2 (5.5) 0.019b 
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Data are median (SD) unless otherwise stated. 
Bold values are statistically significant (p < .05). 
 n = 201 – 224 depending on the variable. 
a T-test. 
b Mann-Whitney U test. 
c Chi-square test. 






Table 2 Differences in bone characteristics between women with and without a history of gestational 
diabetes 
 
Bone characteristic A history of gestational diabetes P 
 Yes 
n = 146 
No 
n = 78 
 
DXA (n = 224)    
Hip BMD (g/cm2) (n = 221) 1.11 (0.12) 1.15 (0.11) 0.034a 
Hip BMD T-score 0.86 (1.04) 1.16 (0.94) 0.034a 
Lumbar spine (L1-L4) BMD (g/cm2) (n = 221) 1.28 (0.13) 1.30 (0.14) 0.371a 
Lumbar spine T-score 0.94 (1.09) 1.08 (1.15) 0.371a 
Whole body BMD (g/cm2) (n = 222) 1.21 (0.09) 1.25 (0.09) 0.003b 
Whole body BMD T-score 1.12 (1.18) 1.60 (1.15) 0.003b 
pQCT    
Distal radius (n = 224)    
BMC (g/cm) 1.11 (0.16) 1.15 (0.16) 0.059b 
TotCSA (mm2) 369.54 (48.38) 383.01 (51.50) 0.053a 
TotDen (mg/cm3) 301.93 (41.06) 301.78 (36.48) 0.978a 
TrabDen (mg/cm3) 179.80 (31.98) 178.99 (32.75) 0.857a 
Proximal radius (n = 224)    
BMC (g/cm) 1.03 (0.13) 1.07 (0.15) 0.079b 
SSIPOL (mm3) 273.78 (52.17) 294.78 (70.52) 0.063b 
TotCSA (mm2) 127.61 (19.76) 131.46 (23.08) 0.340b 
TotDen (mg/cm3) 810.70 (79.16) 809.57 (75.45) 0.989b 
CortDen (mg/cm3) 1168.57 (30.23) 1166.24 (32.83) 0.530b 
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Distal tibia (n = 222)    
BMC (g/cm) 3.21 (0.47) 3.32 (0.42) 0.036b 
TotCSA (mm2) 1060.08 (147.69) 1079.33 (148.97) 0.235b 
TotDen (mg/cm3) 304.25 (32.94) 310.62 (42.16) 0.422b 
TrabDen (mg/cm3) 232.96 (29.71) 233.25 (33.04) 0.947a 
Diaphyseal tibia (n = 221)    
BMC (g/cm) 3.64 (0.47) 3.82 (0.39) 0.004a 
SSIPOL (mm3) 1561.46 (334.57) 1728.80 (281.83) < 0.001b 
TotCSA (mm2) 393.28 (53.07) 418.39 (47.93) 0.001b 
TotDen (mg/cm3) 927.17 (53.09) 916.35 (54.59) 0.155b 
CortDen (mg/cm3) 1192.94 (21.51) 1191.34 (21.67) 0.595a 
CortCSA (mm2) 283.53 (38.96) 298.08 (31.00) 0.003a 
Tibia diaphyseal CortCSA distal TotCSA ratio 26.98 (3.06) 28.07 (5.00) 0.135b 
Data are mean (SD). 
Bold values are statistically significant (p < .05). 
a T-test. 
b Mann-Whitney U test. 
BMC = total bone mineral content; BMD = bone mass density; CortCSA = cortical cross-sectional area; 
CortDen = cortical volumetric density; DXA = dual-energy X-ray absorptiometry; SSIPOL = polar strength 
strain index; pQCT = peripheral quantitative computed tomography; TotCSA = total cross-sectional area; 
TotDen = total volumetric density; TrabDen = trabecular volumetric density
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Table 3 Spearman’s partial correlations between bone characteristics and health- and lifestyle-related factors. Adjusted for age, height, BMI and smoking status (n 
= 190 – 223) 
 
 














DXA         
Hip BMD (g/cm2) -0.183 0.010 0.105 0.090 0.131 0.065 -0.058 0.059 
 P = 0.007 P = 0.884 P = 0.132 P = 0.196 P = 0.062 P = 0.350 P = 0.410 P = 0.411 
Lumbar spine (L1-L4) BMD (g/cm2) -0.180 -0.019 0.084 0.007 0.054 -0.015 0.039 0.009 
 P = 0.008 P = 0.782 P = 0.226 P = 0.920 P = 0.446 P = 0.827 P = 0.577 P = 0.901 
Whole body BMD (g/cm2) -0.248 -0.065 0.119 0.091 0.123 -0.010 -0.064 0.030 
 P < 0.001 P = 0.346 P = 0.086 P = 0.189 P = 0.080 P = 0.887 P = 0.359 P = 0.678 
pQCT         
Distal radius         
BMC (g/cm) -0.324 0.027 0.139 0.089 0.090 0.069 0.020 0.043 
 P < 0.001 P = 0.694 P = 0.043 P = 0.196 P = 0.198 P = 0.321 P = 0.772 P = 0.548 
TotCSA (mm2) -0.219 -0.019 0.060 0.055 0.008 0.075 -0.011 0.072 
 P = 0.001 P = 0.784 P = 0.381 P = 0.425 P = 0.909 P = 0.280 P = 0.869 P = 0.316 
TotDen (mg/cm3) -0.111 -0.011 0.081 -0.015 0.042 0.019 0.044 -0.039 
 P = 0.104 P = 0.878 P = 0.239 P = 0.826 P = 0.550 P = 0.780 P = 0.531 P = 0.588 
TrabDen (mg/cm3) -0.162 0.035 0.133 0.022 0.049 0.055 0.033 0.040 
 P = 0.017 P = 0.604 P = 0.053 P = 0.747 P = 0.479 P = 0.424 P = 0.633 P = 0.578 
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Proximal radius         
BMC (g/cm) -0.349 -0.052 0.154 0.097 0.130 -0.023 0.022 0.051 
 P < 0.001 P = 0.450 P = 0.025 P = 0.161 P = 0.062 P = 0.743 P = 0.757 P = 0.479 
SSIPOL (mm3) -0.301 -0.047 0.083 0.068 0.100 -0.007 -0.010 0.091 
 P < 0.001 P = 0.494 P = 0.226 P = 0.323 P = 0.151 P = 0.918 P = 0.886 P = 0.203 
TotCSA (mm2) -0.354 0.002 0.091 0.094 0.103 -0.025 0.037 0.065 
 P < 0.001 P = 0.972 P = 0.187 P = 0.173 P = 0.140 P = 0.715 P = 0.593 P = 0.366 
TotDen (mg/cm3) 0.048 -0.041 0.036 -0.024 0.028 -0.003 -0.006 -0.020 
 P = 0.481 P = 0.547 P = 0.605 P = 0.729 P = 0.686 P = 0.971 P = 0.930 P = 0.776 
CortDen (mg/cm3) 0.152 -0.106 -0.020 -0.131 -0.077 -0.004 0.004 -0.091 
 P = 0.025 P = 0.120 P = 0.771 P = 0.058 P = 0.271 P = 0.953 P = 0.953 P = 0.204 
Distal tibia         
BMC (g/cm) -0.361 0.021 0.264 0.146 0.160 0.091 0.035 0.074 
 P < 0.001 P = 0.769 P < 0.001 P = 0.038 P = 0.025 P = 0.195 P = 0.628 P = 0.317 
TotCSA (mm2) -0.242 0.008 0.094 0.085 0.103 0.031 0.067 0.079 
 P < 0.001 P = 0.906 P = 0.182 P = 0.227 P = 0.150 P = 0.665 P = 0.351 P = 0.284 
TotDen (mg/cm3) -0.122 0.018 0.146 0.037 0.062 0.100 0.035 -0.020 
 P = 0.080 P = 0.798 P = 0.038 P = 0.604 P = 0.386 P = 0.158 P = 0.627 P = 0.788 
TrabDen (mg/cm3) -0.149 0.027 0.174 0.021 0.053 0.150 -0.003 -0.021 
 P = 0.032 P = 0.699 P = 0.013 P = 0.763 P = 0.462 P = 0.032 P = 0.969 P = 0.780 
Diaphyseal tibia         
BMC (g/cm) -0.330 -0.126 0.216 0.233 0.224 0.007 0.019 0.162 
 P < 0.001 P = 0.071 P = 0.002 P = 0.001 P = 0.002 P = 0.915 P = 0.788 P = 0.027 
SSIPOL (mm3) -0.288 -0.159 0.145 0.178 0.160 -0.002 0.058 0.139 
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 P < 0.001 P = 0.023 P = 0.040 P = 0.011 P = 0.024 P = 0.972 P = 0.419 P = 0.059 
TotCSA (mm2) -0.285 -0.134 0.164 0.187 0.172 -0.011 0.071 0.138 
 P < 0.001 P = 0.056 P = 0.019 P = 0.008 P = 0.015 P = 0.871 P = 0.320 P = 0.061 
TotDen (mg/cm3) -0.052 0.057 0.070 0.081 0.096 0.065 -0.067 0.042 
 P = 0.456 P = 0.414 P = 0.322 P = 0.249 P = 0.178 P = 0.356 P = 0.344 P = 0.565 
CortDen (mg/cm3) 0.030 0.008 -0.093 -0.099 -0.090 -0.007 -0.007 -0.104 
 P = 0.667 P = 0.914 P = 0.185 P = 0.160 P = 0.207 P = 0.926 P = 0.924 P = 0.159 
CortCSA (mm2) -0.340 -0.121 0.237 0.241 0.236 0.006 0.017 0.167 
 P < 0.001 P = 0.084 P = 0.001 P = 0.001 P = 0.001 P = 0.928 P = 0.807 P = 0.023 
CortCSA - distal TotCSA ratio -0.093 -0.086 0.120 0.112 0.144 0.009 -0.055 0.077 
 P = 0.177 P = 0.212 P = 0.084 P = 0.108 P = 0.041 P = 0.892 P = 0.429 P = 0.286 
Bold values are statistically significant (p < .05). 
BMC = total bone mineral content; BMD = bone mass density; BMI = body mass index; cortCSA = cortical cross-sectional area; CortDen = cortical volumetric density; d = day; 
DXA = dual-energy X-ray absorptiometry; fat% = total body fat percentage; HEI = Healthy Eating Index; LTPA = leisure-time physical activity; min = minutes; PA = physical 
activity; SSIPOL = polar strength strain index; pQCT = peripheral quantitative computed tomography; TotCSA = total cross-sectional area; TotDen = total volumetric density; 
TrabDen = trabecular volumetric density
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Table 4 Factors independently associated with bone characteristics (n = 186 – 195) 
 




DXA    
Hip BMD (g/cm2) -0.144 0.105 0.055 
 P = 0.051 P = 0.152 P = 0.453 
Lumbar spine (L1-L4) BMD (g/cm2) -0.142 0.061 0.003 
 P = 0.054 P = 0.408 P = 0.969 
Whole body BMD (g/cm2) -0.207 0.078 0.021 
 P < 0.005 P = 0.293 P = 0.774 
pQCT    
Distal radius    
BMC (g/cm) -0.328 0.064 0.032 
 P < 0.001 P = 0.386 P = 0.666 
TotCSA (mm2) -0.238 0.007 0.073 
 P = 0.001 P = 0.292 P = 0.320 
TotDen (mg/cm3) -0.104 0.035 -0.047 
 P = 0.159 P = 0.631 P = 0.519 
TrabDen (mg/cm3) -0.146 0.103 0.038 
 P = 0.046 P = 0.162 P = 0.610 
Proximal radius    
BMC (g/cm) -0.310 0.046 0.031 
 P < 0.001 P = 0.534 P = 0.673 
SSIPOL (mm3) -0.285 -0.004 0.068 
 P < 0.001 P = 0.953 P = 0.357 
TotCSA (mm2) -0.336 -0.021 0.041 
 P < 0.001 P = 0.774 P = 0.573 
TotDen (mg/cm3) 0.064 0.044 -0.008 
 P = 0.387 P = 0.551 P = 0.915 
CortDen (mg/cm3) 0.141 -0.014 -0.076 
 P = 0.055 P = 0.850 P = 0.299 
Distal tibia    
BMC (g/cm) -0.287 0.192 0.076 
 P < 0.001 P < 0.009 P = 0.303 
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TotCSA (mm2) -0.261 0.072 0.071 
 P < 0.001 P = 0.342 P = 0.344 
TotDen (mg/cm3) -0.066 0.106 -0.031 
 P = 0.379 P = 0.160 P = 0.683 
TrabDen (mg/cm3) -0.102 0.156 -0.030 
 P = 0.176 P = 0.037 P = 0.689 
Diaphyseal tibia    
BMC (g/cm) -0.303 0.127 0.148 
 P < 0.001 P = 0.091 P = 0.048 
SSIPOL (mm3) -0.272 0.063 0.120 
 P < 0.001 P = 0.401 P = 0.110 
TotCSA (mm2) -0.264 0.089 0.123 
 P < 0.001 P = 0.239 P = 0.101 
TotDen (mg/cm3) -0.023 0.040 0.051 
 P = 0.762 P = 0.596 P = 0.503 
CortDen (mg/cm3) 0.014 -0.115 -0.113 
 P = 0.857 P = 0.126 P = 0.134 
CortCSA (mm2) -0.299 0.145 0.156 
 P < 0.001 P = 0.053 P = 0.038 
CortCSA - distal TotCSA ratio -0.039 0.060 0.065 
 P = 0.598 P = 0.418 P = 0.378 
Bold values are statistically significant (p < .05). 
Spearman’s partial correlations adjusted for age, height, BMI, smoking status, HbA1c, screen time, total body fat 
percentage, supervised leisure-time physical activity and Healthy Eating Index. 
BMC = total bone mineral content; BMD = bone mass density; cortCSA = cortical cross-sectional area; CortDen 
= cortical volumetric density; d = day; DXA = dual-energy X-ray absorptiometry; fat% = total body fat 
percentage; HEI = Healthy Eating Index; LTPA = leisure-time physical activity; min = minutes; PA = physical 
activity; SSIPOL = polar strength strain index; pQCT = peripheral quantitative computed tomography; TotCSA 
= total cross-sectional area; TotDen = total volumetric density; TrabDen = trabecular volumetric density 
 
 
